Two hours ago, I pointed to AIGENSYN as a cautionary example. Now it’s ranked number one, up 8.3%. I’m not happy about it at all.
Because its price has barely moved: from 0.01475 to 0.01493, a net change of just 0.2% in two hours. It climbed from third to first purely because the 24-hour window rolled forward. The higher prices from yesterday dropped out of the calculation, making the percentage jump up a notch on its own.
What’s actually changing is something else: open interest rose from 1.3 million to 2.7 million, doubling; the funding rate is -0.29%, and shorts have been steadily adding positions. The price is still 17% below its 24-hour high of 0.01815.
In other words: it’s not that more people are buying—it’s that more people are shorting, and the price hasn’t fallen yet. A big gain, shorts doubling, and the price languishing near the lows—that combination is especially likely to fool beginners.
What I’m doing: staying away, and not shorting it either. With a coin like this, the direction is unclear, and either way you’ll pay tuition.
$AIGENSYN #AIGENSYN #TopGainers
The above is solely my personal opinion and is not investment advice.
Because its price has barely moved: from 0.01475 to 0.01493, a net change of just 0.2% in two hours. It climbed from third to first purely because the 24-hour window rolled forward. The higher prices from yesterday dropped out of the calculation, making the percentage jump up a notch on its own.
What’s actually changing is something else: open interest rose from 1.3 million to 2.7 million, doubling; the funding rate is -0.29%, and shorts have been steadily adding positions. The price is still 17% below its 24-hour high of 0.01815.
In other words: it’s not that more people are buying—it’s that more people are shorting, and the price hasn’t fallen yet. A big gain, shorts doubling, and the price languishing near the lows—that combination is especially likely to fool beginners.
What I’m doing: staying away, and not shorting it either. With a coin like this, the direction is unclear, and either way you’ll pay tuition.
$AIGENSYN #AIGENSYN #TopGainers
The above is solely my personal opinion and is not investment advice.